Showing results (41-50 of 665) with videos related to
Sort By:
Pageof 67
The Milbank Quarterly|March 8, 2022
Compulsory Licensing of Pharmaceuticals in High-Income Countries: A Comparative AnalysisLindor Qunaj, Anna Kaltenboeck, Peter B BachThe Oncologist|March 10, 2015
The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatmentYvonne Bombard, Linda Rozmovits, Maureen Trudeau, et al.European Journal of Cancer (Oxford, England : 1990)|May 8, 2016
The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapyKaren V MacDonald, Yvonne Bombard, Ken Deal, et al.BMJ Open|June 4, 2016
How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experimentDeborah A Marshall, Ken Deal, Yvonne Bombard, et al.American Journal of Human Genetics|July 8, 2022
Digital health-enabled genomics: Opportunities and challengesYvonne Bombard, Geoffrey S Ginsburg, Amy C Sturm, et al.Clinical Colorectal Cancer|October 6, 2010
Diagnosing hereditary colorectal cancerDavid J Gallagher, James D Smith, Kenneth Offit, et al.Advances in Experimental Medicine and Biology|March 19, 2016
Genomic Biomarkers for Breast Cancer RiskMichael F Walsh, Katherine L Nathanson, Fergus J Couch, et al.JAMA|December 9, 2004
Resurrecting treatment histories of dead patients: a study design that should be laid to restPeter B Bach, Deborah Schrag, Colin B BeggThe CRISPR Journal|October 11, 2019
Attitudes of Members of Genetics Professional Societies Toward Human Gene EditingAlyssa J Armsby, Yvonne Bombard, Nanibaa' A Garrison, et al.GMS Health Technology Assessment|March 23, 2017
Q-SEA - a tool for quality assessment of ethics analyses conducted as part of health technology assessmentsAnna Mae Scott, Björn Hofmann, Iñaki Gutiérrez-Ibarluzea, et al.Pageof 67